Evidence map›Paper›PMID 30361493›Full record

ReviewNature reviews. Urology2018

Nonantibiotic prevention and management of recurrent urinary tract infection.

Néha Sihra, Anna Goodman, Rhana Zakri, Arun Sahai, Sachin Malde

Registry-linked trialOpen access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05880602 (Clinical Trial of Nettle and Cranberry Capsules for Prevention of Urinary Tract Infection), which is not on this map. Cited by 135 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed, 5 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05880602 nacompletednot on this mapstarted 2023, after this paper: background citation

Clinical Trial of Nettle and Cranberry Capsules for Prevention of Urinary Tract Infection

TypeinterventionalSponsorChung Shan Medical UniversityRan2023 to 2023Enrolled60ConditionsUrinary Tract InfectionArmsNettle and Cranberry complex capsules, Placebo(starch)
3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 5 syntheses or guidelines pooled it, 301 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Review
  9. Uncomplicated Urinary Tract Infections: From an Invisible Impact to a Visible Change in Complex Care.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Néha SihraDepartment of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Anna GoodmanDepartment of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Rhana ZakriDepartment of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Arun SahaiDepartment of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Sachin MaldeDepartment of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK. sachin.malde@gstt.nhs.uk.
Guy's and St Thomas' NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urinary tract infections (UTIs) are highly prevalent, lead to considerable patient morbidity, incur large financial costs to health-care systems and are one of the most common reasons for antibiotic use worldwide. The growing problem of antimicrobial resistance means that the search for nonantibiotic alternatives for the treatment and prevention of UTI is of critical importance. Potential nonantibiotic measures and treatments for UTIs include behavioural changes, dietary supplementation (such as Chinese herbal medicines and cranberry products), NSAIDs, probiotics, D-mannose, methenamine hippurate, estrogens, intravesical glycosaminoglycans, immunostimulants, vaccines and inoculation with less-pathogenic bacteria. Some of the results of trials of these approaches are promising; however, high-level evidence is required before firm recommendations for their use can be made. A combination of these agents might provide the optimal treatment to reduce recurrent UTI, and trials in specific population groups are required.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalEstrogensFemaleHippuratesHumansMaleMannoseMethenaminePhytotherapyProbioticsRecurrenceSecondary PreventionUrinary Tract InfectionsAnti-Inflammatory Agents, Non-SteroidalEstrogensHippuratesMannoseMethenaminemethenamine hippurate

Identifiers

PMID30361493
OpenAlexW2898597824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.